It is essential to emphasise that any use of GLP-1 medications in Hashimoto's patients would be off-label unless the individual also meets criteria for type 2 diabetes or obesity treatment according to the medication's SmPC
Estimates suggest only about 50% or less is absorbed by the body
Therefore, understanding this physiological process is crucial for preventing frustration and ensuring continued progress successfully
If you develop severe nausea, chest pain, confusion, or signs of hypoglycemia (trembling, intense sweating, vision changes) after drinking, seek immediate medical attention or call emergency services
A healthcare provider must supervise any dosage modifications
Since Compounded Semaglutide is personalized for an individual and not tested on a larger scale, it doesnt have FDA approval